The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020
The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017
The diagnostic value of NO-metabolites (nitrate/nitrite) in pleural effusion Source: Eur Respir J 2005; 26: Suppl. 49, 447s Year: 2005
Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009
Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions? Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
Pleural fluid and plasma D-dimer levels tuberculous pleurisy: the diagnostic value and relation with clinical parameters Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Pleural fluid pH, LDH, total protein, albumin and glucose levels as a predictor of successful pleurodesis for patient with malignant pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002
Procalcitonin and CRP levels in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Pleural NT-PROBNP and albumin gradient (serum-pleural levels difference) in patients with exudative pleural effusion (PE) and previous diuretic therapy Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009
The diagnostic value of CA-125 in pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001
The diagnostic value of pleural fluid IL - 8 level in parapeneumonic effusion and patients with empyema Source: Eur Respir J 2002; 20: Suppl. 38, 440s Year: 2002
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Clinical utility of serum NT-proBNP in the investigation of undiagnosed unilateral pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010
The implication of C-reactive protein in differentiation of various pleural effusion etiologies Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012